Cargando…

The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer

BACKGROUND: Cancer development is mediated by oxidative stress and inflammation, which may correlate with metabolic disorders. The aim of this study was to evaluate antioxidant vitamins status and metabolic parameters in patients with oral cancer according to tumor-node-metastasis (TNM) stages. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Man-Yee, Lee, Bor-Jen, Chang, Po-Sheng, Hsiao, Han-Yu, Hsu, Li-Ping, Chang, Chia-Hua, Lin, Ping-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161249/
https://www.ncbi.nlm.nih.gov/pubmed/32293339
http://dx.doi.org/10.1186/s12885-020-06839-9
_version_ 1783522922902585344
author Chan, Man-Yee
Lee, Bor-Jen
Chang, Po-Sheng
Hsiao, Han-Yu
Hsu, Li-Ping
Chang, Chia-Hua
Lin, Ping-Ting
author_facet Chan, Man-Yee
Lee, Bor-Jen
Chang, Po-Sheng
Hsiao, Han-Yu
Hsu, Li-Ping
Chang, Chia-Hua
Lin, Ping-Ting
author_sort Chan, Man-Yee
collection PubMed
description BACKGROUND: Cancer development is mediated by oxidative stress and inflammation, which may correlate with metabolic disorders. The aim of this study was to evaluate antioxidant vitamins status and metabolic parameters in patients with oral cancer according to tumor-node-metastasis (TNM) stages. METHODS: A total of 194 patients with oral cancer were enrolled in this study. The patients were stratified for four groups according to cancer stages and that the statistics are comparisons across these groups. The levels of antioxidant vitamins (ubiquinone, β-carotene, vitamin A and E), metabolic parameters, oxidative stress, antioxidant enzymes activity, and inflammatory markers were measured. RESULTS: More than half of the subjects had high blood pressure, central obesity, hyperglycemia, and hyperlipidemia regardless of TNM stage. With regard to antioxidant vitamins status, 46 and 94% of patients had β-carotene and ubiquinone deficiency, respectively. Patients in T3 and T4 stages had significantly lower antioxidant enzyme (catalase, p = 0.03) activity and higher inflammatory markers levels (high sensitivity C-reactive protein and interleukin-6, p < 0.01) than patients in the other stages. In addition, the level of β-carotene was negatively associated with waist circumference, and ubiquinone was positively associated with the level of high-density lipoprotein cholesterol (p < 0.05). Higher β-carotene and ubiquinone levels were negatively associated with hypertriglyceridemia and the risk of metabolic syndrome (p < 0.05). CONCLUSIONS: A high proportion of patients with oral cancer had ubiquinone or β-carotene deficiency and metabolic disorders. The level of ubiquinone or β-carotene was negatively associated with the risk of central obesity, hypertriglyceridemia, and metabolic syndrome. Since patients with oral cancer suffer from high oxidative stress and inflammation (particularly in the T3 and T4 stages), supplementation with antioxidant vitamins such as ubiquinone or β-carotene could be preferentially applied.
format Online
Article
Text
id pubmed-7161249
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71612492020-04-22 The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer Chan, Man-Yee Lee, Bor-Jen Chang, Po-Sheng Hsiao, Han-Yu Hsu, Li-Ping Chang, Chia-Hua Lin, Ping-Ting BMC Cancer Research Article BACKGROUND: Cancer development is mediated by oxidative stress and inflammation, which may correlate with metabolic disorders. The aim of this study was to evaluate antioxidant vitamins status and metabolic parameters in patients with oral cancer according to tumor-node-metastasis (TNM) stages. METHODS: A total of 194 patients with oral cancer were enrolled in this study. The patients were stratified for four groups according to cancer stages and that the statistics are comparisons across these groups. The levels of antioxidant vitamins (ubiquinone, β-carotene, vitamin A and E), metabolic parameters, oxidative stress, antioxidant enzymes activity, and inflammatory markers were measured. RESULTS: More than half of the subjects had high blood pressure, central obesity, hyperglycemia, and hyperlipidemia regardless of TNM stage. With regard to antioxidant vitamins status, 46 and 94% of patients had β-carotene and ubiquinone deficiency, respectively. Patients in T3 and T4 stages had significantly lower antioxidant enzyme (catalase, p = 0.03) activity and higher inflammatory markers levels (high sensitivity C-reactive protein and interleukin-6, p < 0.01) than patients in the other stages. In addition, the level of β-carotene was negatively associated with waist circumference, and ubiquinone was positively associated with the level of high-density lipoprotein cholesterol (p < 0.05). Higher β-carotene and ubiquinone levels were negatively associated with hypertriglyceridemia and the risk of metabolic syndrome (p < 0.05). CONCLUSIONS: A high proportion of patients with oral cancer had ubiquinone or β-carotene deficiency and metabolic disorders. The level of ubiquinone or β-carotene was negatively associated with the risk of central obesity, hypertriglyceridemia, and metabolic syndrome. Since patients with oral cancer suffer from high oxidative stress and inflammation (particularly in the T3 and T4 stages), supplementation with antioxidant vitamins such as ubiquinone or β-carotene could be preferentially applied. BioMed Central 2020-04-15 /pmc/articles/PMC7161249/ /pubmed/32293339 http://dx.doi.org/10.1186/s12885-020-06839-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Chan, Man-Yee
Lee, Bor-Jen
Chang, Po-Sheng
Hsiao, Han-Yu
Hsu, Li-Ping
Chang, Chia-Hua
Lin, Ping-Ting
The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer
title The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer
title_full The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer
title_fullStr The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer
title_full_unstemmed The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer
title_short The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer
title_sort risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161249/
https://www.ncbi.nlm.nih.gov/pubmed/32293339
http://dx.doi.org/10.1186/s12885-020-06839-9
work_keys_str_mv AT chanmanyee therisksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer
AT leeborjen therisksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer
AT changposheng therisksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer
AT hsiaohanyu therisksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer
AT hsuliping therisksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer
AT changchiahua therisksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer
AT linpingting therisksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer
AT chanmanyee risksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer
AT leeborjen risksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer
AT changposheng risksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer
AT hsiaohanyu risksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer
AT hsuliping risksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer
AT changchiahua risksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer
AT linpingting risksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer